These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32960649)

  • 21. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials.
    Carpenter JK; Andrews LA; Witcraft SM; Powers MB; Smits JAJ; Hofmann SG
    Depress Anxiety; 2018 Jun; 35(6):502-514. PubMed ID: 29451967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Buprenorphine Effective for Chronic Pain? A Systematic Review and Meta-analysis.
    Lazaridou A; Paschali M; Edwards RR; Gilligan C
    Pain Med; 2020 Dec; 21(12):3691-3699. PubMed ID: 32330264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002207. PubMed ID: 18425880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine Maintenance vs. Placebo for Opioid Dependence.
    Raleigh MF
    Am Fam Physician; 2017 Mar; 95(5):Online. PubMed ID: 28290640
    [No Abstract]   [Full Text] [Related]  

  • 25. Cognitive-Behavioral Therapy for Relationship Distress: Meta-analysis of RCTs with Social Work Implications.
    Gregory VL
    J Evid Based Soc Work (2019); 2021; 18(1):49-70. PubMed ID: 32808591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote cognitive behavioral therapy for panic disorder: A meta-analysis.
    Efron G; Wootton BM
    J Anxiety Disord; 2021 Apr; 79():102385. PubMed ID: 33774557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary on Ling et al. (2013): is there a role for psychotherapy in the treatment of opioid dependence?
    Petry NM
    Addiction; 2013 Oct; 108(10):1799-800. PubMed ID: 24033782
    [No Abstract]   [Full Text] [Related]  

  • 28. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2000; (3):CD002025. PubMed ID: 10908521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
    Herscher M; Fine M; Navalurkar R; Hirt L; Wang L
    Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
    Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
    Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2003; (2):CD002207. PubMed ID: 12804429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2004; (3):CD002207. PubMed ID: 15266465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
    Wakeman SE; Larochelle MR; Ameli O; Chaisson CE; McPheeters JT; Crown WH; Azocar F; Sanghavi DM
    JAMA Netw Open; 2020 Feb; 3(2):e1920622. PubMed ID: 32022884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2002; (2):CD002025. PubMed ID: 12076434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.
    Ling S; Mangaoil R; Cleverley K; Sproule B; Puts M
    Drug Alcohol Depend; 2019 Apr; 197():168-182. PubMed ID: 30831429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 39. Group-based treatment of opioid use disorder with buprenorphine: A systematic review.
    Sokol R; LaVertu AE; Morrill D; Albanese C; Schuman-Olivier Z
    J Subst Abuse Treat; 2018 Jan; 84():78-87. PubMed ID: 29195596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance buprenorphine for opioid users.
    Law FD; Nutt DJ
    Lancet; 2003 Feb; 361(9358):634-5. PubMed ID: 12606172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.